ÂÜÀòÂÒÂ×

Ms. Gluck brings to Dianthus an extensive track record in building and leading highly effective clinical operations functions within the autoimmune space. She most recently served as Senior Vice President, Global Clinical Operations at Aurinia Pharmaceuticals Inc., where she was responsible for creating a clinical organization and executing clinical programs to bring their lead candidate from early phase development through two successful pivotal trials and later to NDA submission and FDA approval. Prior to Aurinia, Ms. Gluck was Vice President of Clinical Operations at Qu Biologics Inc, a company focused on the development of immunotherapeutics. She also served as Vice President and Head of Global Clinical Operations at Vifor Pharmaceuticals following the acquisition of Aspreva Pharmaceuticals, a company collaborating with Roche to develop CellCept (myocophenolate mofetil) for a range of autoimmune diseases. Throughout her career, Ms. Gluck has served in increasingly senior positions at major pharmaceutical companies including Novartis, Organon, and GSK, and has acquired extensive experience with start-up companies.